Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$0.16 - $11.77 $0 - $70
6 Added 0.5%
1,206 $0
Q2 2022

Oct 27, 2022

SELL
$0.26 - $0.87 $1 - $4
-5 Reduced 0.41%
1,200 $1,000
Q2 2022

Aug 15, 2022

SELL
$0.26 - $0.87 $1 - $4
-5 Reduced 0.41%
1,200 $1,000
Q1 2022

Oct 27, 2022

BUY
$0.6 - $1.82 $3 - $9
5 Added 0.42%
1,205 $1,000
Q1 2022

May 13, 2022

BUY
$0.6 - $1.82 $2 - $7
4 Added 0.33%
1,205 $1,000
Q4 2021

Feb 14, 2022

BUY
$1.53 - $3.12 $1 - $3
1 Added 0.08%
1,201 $2,000
Q3 2021

Nov 15, 2021

BUY
$2.69 - $4.94 $3,228 - $5,928
1,200 New
1,200 $4,000

Others Institutions Holding KRBP

About Kiromic Biopharma, Inc.


  • Ticker KRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,843,200
  • Market Cap $14.3M
  • Description
  • Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate tar...
More about KRBP
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.